the segment of baby care products has huge potential, since despite the huge number of children born in the country every year, the segment has not been tapped to its potential. "India is under ...

In an extraordinary initiative to tackle the rising prevalence of atopic dermatitis (AD) in India, Aveeno Baby has set a ...

AreoVeda MD Mayur Abhaya shares the brand’s unique selling proposition, strategies and plans… India’s beauty and personal ...

All Things Baby plans to use its first external funding to accelerate ATB’s expansion across key business areas, including ...

The company's goal is to secure an IPO valuation of Rs 280 crore by 2026. Baby & Mom Retail, a House of Brands and a player ...

All Things Baby secures Rs 30 crore funding to enhance product range, distribution network, and omnichannel presence for ...

The retailer is also planning a public listing, with an IPO anticipated at a valuation of Rs 280 crore by 2026 ...